Stenocare AS (OCSE:STENO) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS ROE % Adjusted to Book Value?

Stenocare AS's ROE % for the quarter that ended in Dec. 2024 was -1,162.98%. Stenocare AS's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Stenocare AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Stenocare AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Stenocare AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS ROE % Adjusted to Book Value Chart

Stenocare AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.19

-9.37

-11.64

-39.51

Stenocare AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-38.66	-10.63	-16.70	-44.46	-

Competitive Comparison of Stenocare AS's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stenocare AS's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Stenocare AS's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Stenocare AS ROE % Adjusted to Book Value Calculation

Stenocare AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-308.65%	/	N/A
	=	N/A

Stenocare AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,162.98%	/	N/A
	=	N/A

Stenocare AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Stenocare AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines